Quest Diagnostics Inc (DGX) showcases a robust financial performance with net revenues of $9.9 billion in 2024.The company's strategic focus on innovation and
The cholesterol test market is experiencing robust growth, driven by increasing consumer demand for preventive healthcare solutions and advancements in...
The increasing demand for clinical laboratory services is mainly driven by the rising prevalence of chronic and infectious diseases, lifestyle-related...
Driven by Demand for Outsourced Biologics Production, the Biopharmaceutical Contract Manufacturing Organization (CMO) Market Surges with Expansion in...
As per Fortune Business Insights’ report, the Esoteric Testing Market share sector attained a worth of USD 22.21 billion in 2022. Forecasts indicate a promising path, foreseeing a Compound Annual…
Rise in prevalence of chronic diseases, increase in funding from government and private sectors, and surge in R&D activities are the major factors which...
The Global Drug Discovery Outsourcing Services Market Size was Valued at USD 3.8 Billion in 2023 and the Worldwide Drug Discovery Outsourcing Services...
The global pharmacogenomics (PGx) market is set to witness substantial growth by 2033. This press release highlights the driving factors behind this...
The global pharmaceutical CDMO market size is anticipated to grow from USD 150 billion to USD 295.07 billion in 10 years. The market will experience rapid...
-- Announced FDA clearance of first-ever IND application for a Prime Editing product, PM359, for the treatment of CGD; initial data from planned Phase 1/2...
WELL Health Technologies sees significant stock rise on positive Q1 2024 results, but limited upside and potential correction may be in store. Read more here.
Companies covered in this report are Intact Medical Corporation, Ethicon Surgical Technologies, Galling SRL, Leica Biosystems Nussle GmbH, Hologic, Inc,...